<DOC>
	<DOCNO>NCT00822302</DOCNO>
	<brief_summary>The plasma concentration high-density lipoprotein ( HDL ) anti-inflammatory , anti-oxidative anti-thrombotic effect addition able remove cholesterol peripheral tissue secretion via liver . The investigator hypothesise elevation plasma HDLs reduce inflammatory response follow removal unstable atherosclerotic plaque carotid artery . Such plaque cause stroke great benefit early surgical removal , however surgical procedure involve significant risk patient . The investigator propose infuse HDL patient prior removal unstable carotid plaque measure change inflammatory response comparison similar placebo control group patient .</brief_summary>
	<brief_title>Trial Evaluate Ability Single Infusion High-Density Lipoprotein ( HDL ) Modulate Markers Cerebral Ischaemia</brief_title>
	<detailed_description>Following write informed consent , patient randomise either placebo active arm study . Bloods take baseline measurement , infusion either saline ( placebo ) rHDL ( active agent ) carry ward . Infusion take 4 hour , active agent infuse 40mg/kg . Just prior CAE , blood collect ( 24 hour post-infusion ) atherosclerotic tissue collect RNA stabilise agent subsequent analysis . Further blood collect 24 hour post-operatively ( 48 hour post-infusion ) . Patients vital sign monitor hourly follow infusion review out-patients 6 week operation .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<criteria>patient list elective carotid endarterectomy pregnant woman woman childbearing age patient impair renal function liver function patient section Mental Health Act</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>atherosclerosis</keyword>
	<keyword>stroke</keyword>
	<keyword>ischaemia</keyword>
</DOC>